Generic Product News (February 2018)

Pharmacy Times, February 2018 Infectious Disease, Volume 84, Issue 2

Generic product news featured in the February 2018 issue of Pharmacy Times.

SILDENAFIL CITRATE

MARKETED BY: Teva

COMPARE TO: Viagra (Pfizer) Teva has launched its generic Viagra (sildenafil citrate) tablets in the United States. Sildenafil tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.

DOSAGE FORM: Tablets: 25 mg, 50 mg, or 100 mg

FOR MORE INFORMATION: tevapharm.com

TRIAMCINOLONE ACETONIDE

MARKETED BY: Amneal Biosciences

COMPARE TO: Kenalog-40 (Bristol- Myers Squibb) Amneal received approval for its generic version of Kenalog-40, triamcinolone acetonide injectable suspension, USP 40 mg/mL multiple dose vials. The product will be sold in 1-mL single-dose vials as well as in 5-mL and 10-mL multiple-dose vials. Kenalog-40 is indicated to treat many types of inflammatory conditions and inflammation.

DOSAGE FORM: Injection

FOR MORE INFORMATION: amneal.com

SEVELAMER CARBONATE

MARKETED BY: Amneal Pharmaceuticals COMPARE TO: Renvela (Genzyme) Amneal Pharmaceuticals has launched sevelamer carbonate tablets, 800 mg, the AB-rated therapeutic equivalent of Renvela. Renvela is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

DOSAGE FORM: Tablets: 800 mg

FOR MORE INFORMATION: amneal.com

SCOPOLAMINE

MARKETED BY: Perrigo Co COMPARE TO: Transderm Scop (Novartis) Perrigo Co and its co-development partner, Aveva Drug Delivery Systems, have launched scopolamine 1.5 mg, their generic equivalent to Transderm Scop. The Transderm Scop transdermal system patch is an anticholinergic indicated for the prevention of nausea and vomiting associated with motion sickness and recovery from anesthesia after surgery in adults.

DOSAGE FORM: Continuous release, circular, flat, tan-colored patch

FOR MORE INFORMATION: perrigo.com